Platelet-activating factor acether (PAF-acether) involvement in acute inflammatory and pain processes.

PubWeight™: 1.36‹?› | Rank: Top 10%

🔗 View Article (PMID 7340441)

Published in Agents Actions on December 01, 1981

Authors

J Bonnet, A M Loiseau, M Orvoen, P Bessin

Articles citing this

Inflammatory actions of platelet activating factor (Pafacether) in guinea-pig skin. Br J Pharmacol (1983) 1.53

Is chronic synovitis an example of reperfusion injury? Ann Rheum Dis (1986) 1.45

Glucocorticoid protection against PAF-acether toxicity in mice. Br J Pharmacol (1983) 1.08

Experimental acute pancreatitis induced by platelet activating factor in rabbits. Am J Pathol (1989) 1.06

Pathophysiological mechanisms of sudden death induced by platelet activating factor. Br J Pharmacol (1984) 1.04

Histamine and leukotriene-independent guinea-pig anaphylactic shock unaccounted for by Paf-acether. Br J Pharmacol (1985) 0.95

Role of platelet activating factor in pathogenesis of acute pancreatitis in rats. Gut (1992) 0.95

The critical role of leukotriene B4 in antigen-induced mechanical hyperalgesia in immunised rats. Br J Pharmacol (2003) 0.90

Inhibition by salmeterol of increased vascular permeability and granulocyte accumulation in guinea-pig lung and skin. Br J Pharmacol (1992) 0.90

Up-regulation of platelet-activating factor synthases and its receptor in spinal cord contribute to development of neuropathic pain following peripheral nerve injury. Mol Pain (2012) 0.85

The role of PAF/PAFR signaling in zymosan-induced articular inflammatory hyperalgesia. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.80

Effectiveness and tolerability of CV-3988, a selective PAF antagonist, after intravenous administration to man. Br J Clin Pharmacol (1988) 0.79

Inhibition of Paf-acether-induced edema of the rat's paw. Agents Actions (1986) 0.75

Platelet-activating factor (PAF-acether): present status. Agents Actions (1981) 0.75

Inflammatory action of PAF-acether in the rat pleural cavity. Agents Actions (1986) 0.75

Articles cited by this

A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther (1957) 6.07

Leukocyte-dependent histamine release from rabbit platelets. The role of IgE, basophils, and a platelet-activating factor. J Exp Med (1972) 5.38

Modulation of human platelet adenylate cyclase by prostacyclin (PGX). Prostaglandins (1977) 3.80

Prostaglandin E-1: a potential mediator of the inflammatory response. Ann N Y Acad Sci (1971) 2.94

Effects of prostaglandins on adenosine 3',5'-monophosphate levels in fat and other tissues. J Biol Chem (1968) 2.56

Imidazole: a selective inhibitor of thromboxane synthetase. Prostaglandins (1977) 2.48

Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils. J Immunol (1979) 2.31

Platelet-activating factor and macrophages. I. Evidence for the release from rat and mouse peritoneal macrophages and not from mastocytes. Eur J Immunol (1979) 2.10

The release of a platelet-activating factor by stimulated rabbit neutrophils. J Immunol (1979) 2.02

Activation of rabbit platelets by platelet-activating factor derived from IgE-sensitized basophils. Characteristics of the aggregation and its dissociation from secretion. J Clin Invest (1977) 1.20

Inhibition of cyclic AMP phosphodiesterase by 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)] ethyl ester 5-methyl ester hydrochloride (YC-93), a potent vasodilator. Biochem Pharmacol (1978) 1.03

Structure-binding-activity analysis of beta-adrenergic amines--I. Binding to the beta receptor and activation of adenylate cyclase. Biochem Pharmacol (1978) 0.91

[Mechanism of anti-inflammatory action of 2-(2-fluoro-4-biphenylyl) propionic acid (flurbiprofen)]. Nihon Yakurigaku Zasshi (1976) 0.84

Articles by these authors

Specific amplification of a DNA sequence common to all Chlamydia trachomatis serovars using the polymerase chain reaction. Res Microbiol (1989) 4.38

Complex polysaccharides as PCR inhibitors in feces: Helicobacter pylori model. J Clin Microbiol (1997) 3.57

Detection of Mycoplasma pneumoniae by using the polymerase chain reaction. J Clin Microbiol (1989) 2.73

[Primary structure of transfer RNA]. Biochimie (1972) 2.43

Typing of Chlamydia trachomatis by restriction endonuclease analysis of the amplified major outer membrane protein gene. J Clin Microbiol (1991) 2.09

Factors determining the specificity of the tRNA aminoacylation reaction. Non-absolute specificity of tRNA-aminoacyl-tRNA synthetase recognition and particular importance of the maximal velocity. Biochimie (1973) 1.56

Studies on tRNA nucleotidyltransferase from baker's yeast. 1. Purification of the enzyme. Protection against thermal inactivation and inhibition by several substrates. Eur J Biochem (1974) 1.44

Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogs. Eur J Pharmacol (1983) 1.43

[Laitinen's stereo-adapter: application to the fractionated cerebral irradiation under stereotaxic conditions]. Neurochirurgie (1990) 1.43

Idiopathic giant oesophageal ulcer in an immunocompetent patient. The efficacy of thalidomide treatment. Gut (1999) 1.39

Combination chemotherapy for multiple myeloma. Cancer (1972) 1.36

Primary structure of the Saccharomyces cerevisiae gene for methionyl-tRNA synthetase. Proc Natl Acad Sci U S A (1983) 1.34

PAF-acether-induced plasma exudation in rat skin is independent of platelets and neutrophils. Microcirc Endothelium Lymphatics (1984) 1.19

Cloning of the yeast methionyl-tRNA synthetase gene. J Biol Chem (1981) 1.18

Interpretation of incomplete reactions in tRNA aminoacylation. Aminoacylation of yeast tRNA Val II with yeast valyl-tRNA synthetase. Eur J Biochem (1972) 1.18

An alternative view of mammalian DNA sequence organization. II. Short repetitive sequences are organized into scrambled tandem clusters in Syrian hamster DNA. J Mol Biol (1981) 1.15

Interpretation of tRNA-mischarging kinetics. Eur J Biochem (1976) 1.11

5 FU infusion with mitomycin-C vs. 5 FU infusion with methyl-CCNU in the treatment of advanced upper gastrointestinal cancer: a Southwest Oncology Group Study. Cancer (1979) 1.10

Spontaneous coronary artery dissection: case report and evidence for a defect in collagen metabolism. Eur Heart J (1986) 1.08

Fibronectin expression and aortic wall elastic modulus in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol (1998) 1.07

A probabilistic analysis of DNA sequence organization. J Mol Biol (1981) 1.06

Detection of cell and tissue surface antigens using up-converting phosphors: a new reporter technology. Anal Biochem (1999) 1.05

Combination therapy for multiple myeloma. Cancer (1977) 1.03

Abnormal cholesterol metabolism in imipramine-treated fibroblast cultures. Similarities with Niemann-Pick type C disease. Biochim Biophys Acta (1990) 1.02

Tumor necrosis factor-alpha stimulates ICAM-1 expression in human vascular smooth muscle cells. Arterioscler Thromb (1993) 1.00

Regulation of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 in human vascular smooth muscle cells. Circ Res (1994) 1.00

The integrin very late antigen-4 is expressed in human smooth muscle cell. Involvement of alpha 4 and vascular cell adhesion molecule-1 during smooth muscle cell differentiation. Circ Res (1997) 0.99

Effects of ceramide on apoptosis, proteoglycan degradation, and matrix metalloproteinase expression in rabbit articular cartilage. Biochem Biophys Res Commun (2000) 0.99

The role of dental canal fillings in the development of Aspergillus sinusitis. A report of 85 cases. Arch Otorhinolaryngol (1989) 0.98

Therapeutic value of a cardioprotective agent in patients with severe ischaemic cardiomyopathy. Eur Heart J (1990) 0.97

Vitronectin expression and interaction with receptors in smooth muscle cells from human atheromatous plaque. Arterioscler Thromb Vasc Biol (1998) 0.96

An overlapping CArG/octamer element is required for regulation of desmin gene transcription in arterial smooth muscle cells. Dev Biol (2000) 0.96

Characterisation of cyclooxygenase 1 and 2 expression in mouse resident peritoneal macrophages in vitro; interactions of non steroidal anti-inflammatory drugs with COX2. Biochim Biophys Acta (1995) 0.95

Lack of correlation between affinity of the tRNA for the aminoacyl-tRNA synthetase and aminoacylation capacity as studied with modified tRNAPhe. Eur J Biochem (1979) 0.95

Dependency of the Paf-acether induced bronchospasm on the lipoxygenase pathway in the guinea-pig. Prostaglandins (1983) 0.95

The cytosolic and glycosomal glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma brucei. Kinetic properties and comparison with homologous enzymes. Eur J Biochem (1991) 0.94

The corrected nucleotide sequence of valine tRNA from baker's yeast. Biochimie (1974) 0.93

Preparation and microscopic visualization of multicolor luminescent immunophosphors. Cytometry (1992) 0.93

Vincristine, BCNU, doxorubicin, and prednisone (VBAP) combination in the treatment of relapsing or resistant multiple myeloma: a Southwest Oncology Group study. Cancer Treat Rep (1982) 0.93

Improved microplate immunoenzymatic assay of PCR products for rapid detection of Mycoplasma pneumoniae. Mol Cell Probes (1995) 0.92

Influence of various factors on the recognition specificity of tRNAs by yeast valyl-tRNA synthetase. Eur J Biochem (1975) 0.92

cDNA library construction from small amounts of unfractionated RNA: association of cDNA synthesis with polymerase chain reaction amplification. Anal Biochem (1990) 0.90

Evidence of early subchondral bone changes in the meniscectomized guinea pig. A densitometric study using dual-energy X-ray absorptiometry subregional analysis. Osteoarthritis Cartilage (1999) 0.90

Fructose 2,6-bisphosphate and the control of glycolysis by glucocorticoids and by other agents in rat hepatoma cells. Cancer Res (1985) 0.89

Lack of ceramide generation in TF-1 human myeloid leukemic cells resistant to ionizing radiation. Cell Death Differ (1998) 0.88

Emotional, physical and sexual violence against women before or during pregnancy. BJOG (2000) 0.87

Improved leishmanicidal effect of phosphorotioate antisense oligonucleotides by LDL-mediated delivery. Biochim Biophys Acta (1995) 0.87

Short- and long-term risk factors for sudden death in patients with stable angina. Int J Cardiol (2001) 0.87

Phosphorescent platinum/palladium coproporphyrins for time-resolved luminescence microscopy. J Histochem Cytochem (1999) 0.87

Early and long-term (one-year) effects of the association of aspirin and oral anticoagulant on thrombi and morbidity after replacement of the mitral valve with the St. Jude medical prosthesis: a clinical and transesophageal echocardiographic study. J Am Coll Cardiol (2000) 0.87

Adjuvant therapy in large bowel adenocarcinoma: long-term results of a Southwest Oncology Group Study. J Clin Oncol (1988) 0.87

Platinum porphyrins as phosphorescent label for time-resolved microscopy. J Histochem Cytochem (1997) 0.86

Iridium-192 interstitial therapy for squamous cell carcinoma of the penis. Int J Radiat Oncol Biol Phys (1992) 0.86

Effects of ceramide on aggrecanase activity in rabbit articular cartilage. Biochem Biophys Res Commun (2001) 0.86

Isolation and characterization of the yeast aspartyl-tRNA synthetase gene. Gene (1985) 0.86

Granulocytic sarcoma of the jejunum: a rare cause of small bowel obstruction. Am J Gastroenterol (1998) 0.86

Tryptophanyl-tRNA synthetase is a major soluble protein species in bovine pancreas. Biochim Biophys Acta (1986) 0.85

Different expression of the two dopaminergic D2 receptors, D2415 and D2444, in two types of lactotroph each characterised by their response to dopamine, and modification of expression by sex steroids. Endocrinology (1991) 0.85

Improved survival duration with combination chemotherapy induction for multiple myeloma: a Southwest Oncology Group Study. J Clin Oncol (1986) 0.85

IL-2-dependent expression of genes involved in cytoskeleton organization, oncogene regulation, and transcriptional control. J Immunol (1999) 0.85

The expression of CD70 and CD80 by gene-modified tumor cells induces an antitumor response depending on the MHC status. Cancer Gene Ther (2000) 0.84

Studies on the mechanism of deacylation of aminoacyl-tRNAs by aminoacyl-tRNA synthetases in the absence of adenosine monophosphate and pyrophosphate. Biochimie (1974) 0.84

Farnesylated RhoB inhibits radiation-induced mitotic cell death and controls radiation-induced centrosome overduplication. Cell Death Differ (2005) 0.84

Familial dilated cardiomyopathy: clinical features in French families. Eur J Heart Fail (1999) 0.84

An open-label study of thalidomide for maintenance therapy in responders to infliximab in chronically active and fistulizing refractory Crohn's disease. Aliment Pharmacol Ther (2002) 0.83

Presence of immunoreactive material in Niemann-Pick type A placenta using anti-sphingomyelinase rabbit gammaglobulins. Biochim Biophys Acta (1987) 0.83

Chemoimmunotherapy for multiple myeloma. Cancer (1981) 0.83

Monocyte/macrophage recruitment and expression of endothelial adhesion proteins in human atherosclerotic lesions. Atherosclerosis (1996) 0.83

Lysyl oxidase deficiency: a new cause of human arterial dissection. Heart (2005) 0.83

An alternative splicing modifies the C-terminal end of tryptophanyl-tRNA synthetase in murine embryonic stem cells. J Mol Biol (1994) 0.83

Correction of aminoacylation errors: evidence for a non significant role of the aminoacyl-tRNA synthetase catalysed deacylation of aminoacyl-tRNAs. FEBS Lett (1974) 0.83

5FU infusion with mitomycin-C versus 5 FU infusion with methyl-CCNU in the treatment of advanced colon cancer: a Southwest Oncology Group Study. Cancer (1978) 0.82

A human metapneumovirus outbreak at a community hospital in England, July to September 2010. Euro Surveill (2012) 0.82

Specific evaluation of localized bone mass and bone loss in the rat using dual-energy X-ray absorptiometry subregional analysis. Osteoporos Int (1995) 0.81

Fractionated radiotherapy of small inoperable lesions of the brain using a non-invasive stereotactic frame. Int J Radiat Oncol Biol Phys (1991) 0.80

Vascular cell adhesion molecule-1 gene expression during human smooth muscle cell differentiation is independent of NF-kappaB activation. J Biol Chem (1999) 0.80

Purification of guinea pig YKL40 and modulation of its secretion by cultured articular chondrocytes. J Cell Biochem (1998) 0.80

Reflection contrast microscopy of ultrathin sections in immunocytochemical localization studies: a versatile technique bridging electron microscopy with light microscopy. Histochemistry (1993) 0.80

[Cardiac complications of dermatopolymyositis. Apropos of 56 cases]. Arch Mal Coeur Vaiss (1987) 0.80

Preparation of an anti-acid sphingomyelinase monoclonal antibody for the quantitative determination and polypeptide analysis of lysosomal sphingomyelinase in fibroblasts from normal and Niemann-Pick type A patients. J Immunol Methods (1993) 0.80

Use of ferro-electric liquid crystal shutters for time-resolved fluorescence microscopy. Cytometry (1994) 0.79

Myelin P0 glycoprotein: identification of the site phosphorylated in vitro and in vivo by endogenous protein kinases. J Neurochem (1995) 0.79

Reflection contrast microscopy. Visualization of (peroxidase-generated) diaminobenzidine polymer products and its underlying optical phenomena. Histochemistry (1988) 0.79

Comparison of fibrinolytic treatment with interruption of the inferior caval vein in the prevention of pulmonary embolism. Int J Cardiol (1986) 0.79

[Pharmacology of a new cardiotropic drug : (dichloro-2, 3-methoxy 4) phenyl furyl-2-0-(diethylamino-ethyl)-ketone-oxime (ANP 4364)]. C R Acad Sci Hebd Seances Acad Sci D (1975) 0.79

Multidisciplinary network in heart failure management in a community-based population: results and benefits at 2 years. Int J Cardiol (2008) 0.79

An alternative view of mammalian DNA sequence organization. I. Repetitive sequence interspersion in Syrian hamster DNA: a model system. J Mol Biol (1981) 0.79

1,3-Diaryl-4,5,6,7-tetrahydro-2H-isoindole derivatives: a new series of potent and selective COX-2 inhibitors in which a sulfonyl group is not a structural requisite. J Med Chem (2000) 0.79

Kinetics of adventitial repair in the rat carotid model. Coron Artery Dis (2001) 0.79

Effects of parathyroid hormone and agonists of the adenylyl cyclase and protein kinase C pathways on bone cell proliferation. Bone (1996) 0.79

Risk factors for progression of atherosclerosis six months after balloon angioplasty of coronary stenosis. Am J Cardiol (1990) 0.79

Cardioprotective effect of trimetazidine in severe ischemic cardiomyopathy. Cardiovasc Drugs Ther (1990) 0.78

Quantitative analysis of polymerase chain reaction products using biotinylated dUTP incorporation. Anal Biochem (1993) 0.78

Encapsulation of deoxyribonucleic acid molecules in silica and hybrid organic-silica gels. J Mater Sci Mater Med (2001) 0.78

The farnesyltransferase inhibitor FTI-277 suppresses the 24-kDa FGF2-induced radioresistance in HeLa cells expressing wild-type RAS. Radiat Res (1999) 0.78

Study of the role of the acceptor stem in the interactions between tRNAs and aminoacyl-tRNA synthetases. Nucleic Acids Res (1975) 0.78

Mechanism of inhibition of tumor necrosis factor production by chlorpromazine and its derivatives in mice. Eur J Pharmacol (1996) 0.78

Morphometry of the human splenic artery: muscular columns, morphofunctional aspects and developmental implications. Histol Histopathol (1998) 0.78